Product Highlight-Wegovy
11 Mar 2026
- Wegovy delivers ≥20% weight loss among 1 in 3 PwO1-3
- Wegovy delivers weight loss from the right places - 84% from fat mass*4
- Only Wegovy delivers proven CV benefits with 20% reduction of CV death, heart attack, and stroke in PwO5
- Wegovy enables 46% decrease in constant thoughts about food6,7
References: 1. Wilding et al. N Engl J Med 2021;384:989-1002.
2. Wadden et al. JAMA 2021;325:1403-13.
3. Rubino et al. JAMA 2021;325:1414-25.
4. Hjelmesæth J et al. Presented at EASD 2025, Vienna, Austria, 15-19 September 2025.
5. Lincoff AM, et al. N Engl J Med. 2023;389:2221–32.
6. Wharton S et al. Obesity (Silver Spring) 2023;31:703-715.
7. Arnaut T et al. Oral presentation at EASD 2025, Vienna, Austria, 15-19 September 2025.
For healthcare professionals only.
NOVO NORDISK PHARMA (M) SDN BHD
Company No: 240770-W
Menara 1 Sentrum, Level 16, No. 201, Jalan Tun Sambanthan, 50470 Kuala Lumpur
Tel: (+60-3) 2265 7300 • Fax: (+60-3) 2276 5161 • Website: www.novonordisk.com
